Cancer drugs promote stem cell properties of colorectal cancer

Scientists have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells. This can lead to the accumulation of tumor cells with stem cell characteristics that are resistant to many therapies and can lead to relapses. The researchers thus provide a possible explanation for why these drugs are not effective in colorectal cancer.


Click here for original story, Cancer drugs promote stem cell properties of colorectal cancer


Source: ScienceDaily